This article is more than 5 years old. Information may no longer be current.

VIDEO: Glazebrook discusses outcomes of hemiarthroplasty of the toe with synthetic implant revised to fusion

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SEATTLE — At the American Orthopaedic Foot and Ankle Society Annual Meeting, Mark A. Glazebrook, MD, MSc, PhD, spoke about a study that compared results of hemiarthroplasty performed with the Cartiva Synthetic Implant and revised to fusion vs. primary fusion. He said there were no significant differences in clinical outcomes between the primary and revision fusion groups.